149 related articles for article (PubMed ID: 14748557)
1. Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas.
Mawrin C; Schulz S; Pauli SU; Treuheit T; Diete S; Dietzmann K; Firsching R; Schulz S; Höllt V
J Neuropathol Exp Neurol; 2004 Jan; 63(1):13-9. PubMed ID: 14748557
[TBL] [Abstract][Full Text] [Related]
2. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
[TBL] [Abstract][Full Text] [Related]
4. Frequent expression of immunoreactive somatostatin receptors in cervical and endometrial cancer.
Schulz S; Schmitt J; Weise W
Gynecol Oncol; 2003 Jun; 89(3):385-90. PubMed ID: 12798699
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison.
Sharma I; Siraj F; Sharma KC; Singh A
J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653
[TBL] [Abstract][Full Text] [Related]
6. Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.
Bhandari S; Watson N; Long E; Sharpe S; Zhong W; Xu SZ; Atkin SL
J Histochem Cytochem; 2008 Aug; 56(8):733-43. PubMed ID: 18443363
[TBL] [Abstract][Full Text] [Related]
7. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
Schulz S; Pauli SU; Schulz S; Händel M; Dietzmann K; Firsching R; Höllt V
Clin Cancer Res; 2000 May; 6(5):1865-74. PubMed ID: 10815909
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
Schulz S; Schulz S; Schmitt J; Wiborny D; Schmidt H; Olbricht S; Weise W; Roessner A; Gramsch C; Höllt V
Clin Cancer Res; 1998 Sep; 4(9):2047-52. PubMed ID: 9748118
[TBL] [Abstract][Full Text] [Related]
10. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.
Reddy PS; Umesh S; Thota B; Tandon A; Pandey P; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Biol Ther; 2008 May; 7(5):663-8. PubMed ID: 18728403
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
Vlodavsky E; Soustiel JF
J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues.
Unger N; Ueberberg B; Schulz S; Saeger W; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):482-9. PubMed ID: 22976314
[TBL] [Abstract][Full Text] [Related]
13. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
14. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.
Wykosky J; Gibo DM; Stanton C; Debinski W
Clin Cancer Res; 2008 Jan; 14(1):199-208. PubMed ID: 18172271
[TBL] [Abstract][Full Text] [Related]
16. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M
Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of somatostatin receptors sst2A in human tumors.
Reubi JC; Kappeler A; Waser B; Laissue J; Hipkin RW; Schonbrunn A
Am J Pathol; 1998 Jul; 153(1):233-45. PubMed ID: 9665484
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Kuriyama H; Lamborn KR; O'Fallon JR; Iturria N; Sebo T; Schaefer PL; Scheithauer BW; Buckner JC; Kuriyama N; Jenkins RB; Israel MA
Neuro Oncol; 2002 Jul; 4(3):179-86. PubMed ID: 12084348
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
